Endo International plc Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019
OPERATING ACTIVITIES:
NET LOSS
Adjustments to reconcile Net loss to Net cash provided by operating activities:
Depreciation and amortization
Inventory step-up
Share-based compensation
Amortization of debt issuance costs and discount
Deferred income taxes
Change in fair value of contingent consideration
Loss on extinguishment of debt
Acquired in-process research and development charges
Asset impairment charges
Non-cash reorganization items, net
Gain on sale of business and other assets
Other

Changes in assets and liabilities which provided (used) cash:
Accounts receivable
Inventories
Prepaid and other assets
Accounts payable, accrued expenses and other liabilities
Income taxes payable/receivable, net
Net cash provided by operating activities
INVESTING ACTIVITIES:
Capital expenditures, excluding capitalized interest
Capitalized interest payments
Decrease in notes receivable
Proceeds from the U.S. Government Cooperative Agreement
Acquisitions, including in-process research and development, net of cash and restricted cash acquired
Proceeds from sales and maturities of investments
Product acquisition costs and license fees
Proceeds from sale of business and other assets
Other investing activities
Net cash used in investing activities

FINANCING ACTIVITIES:
Proceeds from issuance of notes, net
Proceeds from issuance of term loans
Proceeds from issuance of term loans, net
Repayments of notes
Repayments of term loans
Proceeds from draw of revolving debt
Repayments of revolving debt
Adequate protection payments
Repayments of other indebtedness
Payments for debt issuance and extinguishment costs
Payments for contingent consideration
Payments of tax withholding for restricted shares
Proceeds from exercise of options
Net cash used in financing activities

Movement in cash held for sale
Effect of foreign exchange rate
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS
CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS, BEGINNING OF PERIOD
CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS, END OF PERIOD
SUPPLEMENTAL INFORMATION:
Cash paid for interest, excluding capitalized interest and adequate protection payments
Cash paid for income taxes, gross
Cash refunds from income taxes, gross
Cash paid into Qualified Settlement Funds for mesh legal settlements
Cash paid out of Qualified Settlement Funds for mesh legal settlements
Other cash distributions for mesh legal settlements
SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES:
Acquisitions, including in-process research and development, accrued in the period but not yet paid

Comments